Cardiovascular pharmacogenomics and individualized drug therapy - Wikidata - wikimedia - TriplyDB

Cardiovascular pharmacogenomics and individualized drug therapy

Cardiovascular pharmacogenomics and individualized drug therapy

http://www.wikidata.org/entity/Q35025518

about

Variants identified in a GWAS meta-analysis for blood lipids are associated with the lipid response to fenofibrate Pharmacogenetics of heart failure.Strategic plan for lung vascular research: An NHLBI-ORDR Workshop Report.Genetics of atrial fibrillation: implications for future research directions and personalized medicine.Genotype-based clinical trials in cardiovascular disease.Factors affecting the development of adverse drug reactions to β-blockers in hospitalized cardiac patient population Ten questions about systems biology.Principles for Developing Patient Avatars in Precision and Systems Medicine.Genetic Risk and Altering Lipids With Lifestyle Changes and Metformin: Is Fate Modifiable?Exercise training response heterogeneity: physiological and molecular insights.

P2860

Q28484684-4E3CB8A1-A8D9-48DD-ADCF-DC660D2094B7 Q33986293-DC94860F-34FF-45A5-BA3A-B147910E8A9C Q34535086-8A9A48CE-64D4-47B8-980A-32FAD539E0CA Q34710843-E81A6C45-E071-40DB-8D13-A453B1E90B7E Q36393911-AEC318C1-6F88-45CF-86FE-DB7961C73718 Q37158873-1E2188F0-29DD-4A53-B767-7C4EB6D719C4 Q37827645-004F8E57-FCA6-462D-8F2B-68DE3FA5A420 Q40345161-116EB01F-B24D-4D7F-919A-6D3EBEB918D9 Q45516535-0FCAA02D-04D7-4C67-BE52-141806DB9F9E Q50069954-63CF8EA4-0D8B-4823-B661-41A541B3F635

P2860

Cardiovascular pharmacogenomics and individualized drug therapy

http://www.wikidata.org/entity/Q35025518

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Cardiovascular pharmacogenomics and individualized drug therapy

@ast

Cardiovascular pharmacogenomics and individualized drug therapy

@en

type

label

Cardiovascular pharmacogenomics and individualized drug therapy

@ast

Cardiovascular pharmacogenomics and individualized drug therapy

@en

prefLabel

Cardiovascular pharmacogenomics and individualized drug therapy

@ast

Cardiovascular pharmacogenomics and individualized drug therapy

@en

P1433

Q35025518-E688BC2C-455D-47BF-9497-C9CFADCFA000

P1476

Q35025518-DE059FC9-B4BB-4313-A47B-B7F3C29EC84C

P2093

Q35025518-503F32AA-2639-45C8-B645-91811A362B4C

P2860

Q35025518-12114F12-9090-4DB9-ACE0-F2EE71CC5A7B

Q35025518-18C5AF2F-44A1-431B-9BA3-AB7D2F0DED98

Q35025518-1F06ADB2-77F3-45CD-99DD-CB911D6F4D56

Q35025518-1FB154C4-542D-46A1-828E-084EE5A547F6

Q35025518-36D3FCD8-48F2-4F7E-B8C1-9CA8AD062B45

Q35025518-3A43AFAE-A234-4542-BDB5-5F9E00F84BAC

Q35025518-3F123F05-A93B-48E6-87FC-41722E7C4011

Q35025518-489414FF-7F42-4078-89B8-D8D7DFAA0104

Q35025518-4CB70782-5054-498E-AFED-919A363DE2E7

Q35025518-508AC39D-E087-40FB-81F8-F8951C5B218A

P304

Q35025518-1F378CB1-9B2C-4009-8178-8FE190DE1368

P31

Q35025518-4CE76F50-EC59-4854-920E-670197E974BE

P356

Q35025518-FA4AD0CE-8D27-4D45-9D14-5695C2A66774

P407

Q35025518-813D3185-2DAC-44F5-80D3-4CFC76EC1456

P433

Q35025518-F8D57A37-C39F-4225-A70B-44473EA8934C

P478

Q35025518-27C703BD-9449-47A4-BC2D-BA5D20EADAF5

P50

Q35025518-DBDACFC5-0FCE-4105-AC8D-525D10CB5B6D

P577

Q35025518-28BE8341-1D7F-4240-90DE-4C8C4F9D6CBB

P5875

Q35025518-6F578C22-4BF5-43B0-ABF1-00B6690BC099

P698

Q35025518-32AE1E9D-0DD4-47AA-B744-0A7FFF04D879

P921

Q35025518-3D9E3629-52AB-4DAD-A087-E25045168F54

P932

Q35025518-791A46EC-4D39-4290-BE6E-F92F84EBA48C

P356

NRCARDIO.2009.154

P1433

Nature Reviews Cardiology

P1476

Cardiovascular pharmacogenomics and individualized drug therapy

@en

P2093

Naveen L Pereira

http://www.w3.org/2001/XMLSchema#string

P2860

Racial differences in the frequencies of cardiac beta(1)-adrenergic receptor polymorphisms: analysis of c145A>G and c1165G>C

Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine

SLCO1B1 variants and statin-induced myopathy--a genomewide study

Some statistical data on atypical cholinesterase of human serum.

Pharmacogenomics: candidate gene identification, functional validation and mechanisms.

Estimation of the warfarin dose with clinical and pharmacogenetic data.

A four amino acid deletion polymorphism in the third intracellular loop of the human alpha 2C-adrenergic receptor confers impaired coupling to multiple effectors.

Drug reactions enzymes, and biochemical genetics.

How to interpret a genome-wide association study.

P304

632-638

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRCARDIO.2009.154

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Richard Weinshilboum

P577

2009-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26767239

http://www.w3.org/2001/XMLSchema#string

P698

19707183

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics

P932

3108370

http://www.w3.org/2001/XMLSchema#string